TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Long Term Cocoa Flavanol Intake on Blood Pressure and Platelet Function in Healthy Adults, Part 1
Brief Summary: Flavanols are plant-derived compounds commonly present in the human diet. Examples of flavanol-containing foods and beverages are apples, chocolate, tea, wine, berries, pomegranate and nuts. The consumption of flavanol-containing foods and beverages has been associated with improvements in cardiovascular health. In this study, the investigators hope to learn more about the effects of the consumption of increasing amounts of cocoa flavanols on blood pressure, platelet function and other metabolic parameters in healthy humans. This study was followed by a second study that aimed at investigating the effects of long term consumptions of cocoa flavanols on blood pressure, platelet function and other metabolic parameters in healthy humans.


Options:
A: Arm Label: Dark chocolate, dietary counselling; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Dark chocolate | Arm Label: Dietary counselling; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Dark chocolate, Other: Dietary counselling | Intervention Type: DIETARY_SUPPLEMENT; Name: Dark chocolate; Assigned to Arm(s): Dark chocolate, dietary counselling, Dietary counselling | Intervention Type: OTHER; Name: Dietary counselling; Assigned to Arm(s): Dietary counselling
B: Arm Label: Dark chocolate; Type: EXPERIMENTAL; Interventions: Other: Flavanol-rich dark chocolate | Arm Label: Placebo chocolate; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo Chocolate | Intervention Type: OTHER; Name: Flavanol-rich dark chocolate; Assigned to Arm(s): Dark chocolate | Intervention Type: OTHER; Name: Placebo Chocolate; Assigned to Arm(s): Placebo chocolate
C: Arm Label: Inofolic NRT; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Inofolic NRT | Intervention Type: DIETARY_SUPPLEMENT; Name: Inofolic NRT; Assigned to Arm(s): Inofolic NRT
D: Arm Label: Cocoa Flavanol intake escalation; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Mars Cocoa Extract Capsules | Intervention Type: DIETARY_SUPPLEMENT; Name: Mars Cocoa Extract Capsules; Assigned to Arm(s): Cocoa Flavanol intake escalation

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Characterizing Variability in Hearing Aid Outcomes Among Older Adults
Brief Summary: The goal of this project is to find out if the way a hearing aid processes a sound signal should be determined in part by an individual's cognitive characteristics. We anticipate that the outcome of this work will be a battery of assessments that will guide hearing aid processing for older patients with hearing loss.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Intervention | Arm Label: Attention; Type: EXPERIMENTAL; Interventions: Other: Attention | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Control | Intervention Type: OTHER; Name: Intervention; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Attention; Assigned to Arm(s): Attention | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
B: Arm Label: IVR Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: IVR Intervention Group | Arm Label: IVR Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: IVR Intervention Group; Assigned to Arm(s): IVR Intervention Group
C: Arm Label: PHR Group; Type: ACTIVE_COMPARATOR; Interventions: Other: SANOIA Website | Arm Label: Non-PHR Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: SANOIA Website; Assigned to Arm(s): PHR Group
D: Arm Label: Hearing Aid Fitting Order A; Type: ACTIVE_COMPARATOR; Interventions: Device: Hearing Aid Fitting A, Device: Hearing Aid Fitting B | Arm Label: Hearing Aid Fitting Order B; Type: ACTIVE_COMPARATOR; Interventions: Device: Hearing Aid Fitting A, Device: Hearing Aid Fitting B | Intervention Type: DEVICE; Name: Hearing Aid Fitting A; Assigned to Arm(s): Hearing Aid Fitting Order A, Hearing Aid Fitting Order B | Intervention Type: DEVICE; Name: Hearing Aid Fitting B; Assigned to Arm(s): Hearing Aid Fitting Order A, Hearing Aid Fitting Order B

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Healthy Nutrition and Energy Restriction as Cancer Prevention Strategies: a Randomized Controlled Intervention Trial
Brief Summary: This study evaluates the effect of intermittent calorie restriction versus continued calorie restriction on weight loss, gene expression profile of subcutaneous adipose tissue and abdominal fat distribution.


Options:
A: Arm Label: Intermittent Energy Restriction; Type: EXPERIMENTAL; Interventions: Behavioral: Intermittent Energy Restriction | Arm Label: Continuous Energy Restriction; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Continuous Energy Restriction | Intervention Type: BEHAVIORAL; Name: Intermittent Energy Restriction; Assigned to Arm(s): Intermittent Energy Restriction | Intervention Type: BEHAVIORAL; Name: Continuous Energy Restriction; Assigned to Arm(s): Continuous Energy Restriction
B: Arm Label: Early Time-Restricted Feeding; Type: EXPERIMENTAL; Interventions: Behavioral: Early Time-Restricted Feeding, Behavioral: Structured Weight Loss Program | Arm Label: Control Schedule; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control Schedule, Behavioral: Structured Weight Loss Program | Intervention Type: BEHAVIORAL; Name: Early Time-Restricted Feeding; Assigned to Arm(s): Early Time-Restricted Feeding | Intervention Type: BEHAVIORAL; Name: Control Schedule; Assigned to Arm(s): Control Schedule | Intervention Type: BEHAVIORAL; Name: Structured Weight Loss Program; Assigned to Arm(s): Control Schedule, Early Time-Restricted Feeding
C: Arm Label: TRF; Type: EXPERIMENTAL; Interventions: Behavioral: Time Restricted Feeding | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Time Restricted Feeding; Assigned to Arm(s): TRF | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual care
D: Arm Label: Intermittent Calorie Restriction; Type: EXPERIMENTAL; Interventions: Other: Calorie Restriction | Arm Label: Continuous Calorie Restriction; Type: EXPERIMENTAL; Interventions: Other: Calorie Restriction | Arm Label: Healthy Nutrition; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Calorie Restriction; Assigned to Arm(s): Continuous Calorie Restriction, Intermittent Calorie Restriction

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, Multi-Center, Randomized, Double-blind, Placebo Controlled, Two-way Cross-over Clinical Study to Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD
Brief Summary: The purpose of this study is to evaluate the safety and efficacy of ORADUR®-Methylphenidate in children and adolescents with ADHD.


Options:
A: Arm Label: Placebo First, then ORADUR®; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo First, then ORADUR® | Arm Label: ORADUR® First, then Placebo; Type: EXPERIMENTAL; Interventions: Drug: ORADUR® First, then Placebo | Intervention Type: DRUG; Name: Placebo First, then ORADUR®; Assigned to Arm(s): Placebo First, then ORADUR® | Intervention Type: DRUG; Name: ORADUR® First, then Placebo; Assigned to Arm(s): ORADUR® First, then Placebo
B: Arm Label: Lisdexamfetamine dimesylate; Type: EXPERIMENTAL; Interventions: Drug: Lisdexamfetamine dimesylate | Arm Label: Methylphenidate Hydrochloride; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methylphenidate Hydrochloride | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Lisdexamfetamine dimesylate; Assigned to Arm(s): Lisdexamfetamine dimesylate | Intervention Type: DRUG; Name: Methylphenidate Hydrochloride; Assigned to Arm(s): Methylphenidate Hydrochloride | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Methylphenidate Transdermal System (MTS); Type: ACTIVE_COMPARATOR; Interventions: Drug: Methylphenidate Transdermal System | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Methylphenidate Transdermal System; Assigned to Arm(s): Methylphenidate Transdermal System (MTS) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Lisdexamfetamine Dimesylate; Type: EXPERIMENTAL; Interventions: Drug: Lisdexamfetamine dimesylate | Arm Label: Methylphenidate Hydrochloride; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methylphenidate Hydrochloride | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Lisdexamfetamine dimesylate; Assigned to Arm(s): Lisdexamfetamine Dimesylate | Intervention Type: DRUG; Name: Methylphenidate Hydrochloride; Assigned to Arm(s): Methylphenidate Hydrochloride | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dexamethasone for Prophylaxis of Acute Mountain Sickness in Patients With Chronic Obstructive Pulmonary Disease Travelling to Altitude
Brief Summary: Randomized, placebo controlled trial evaluating efficacy of dexamethasone in preventing acute mountain sickness in lowlanders with chronic obstructive lung disease travelling from 700 m to 3200 m.


Options:
A: Arm Label: Ibuprofen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ibuprofen | Arm Label: acetazolamide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Acetazolamide | Intervention Type: DRUG; Name: Ibuprofen; Assigned to Arm(s): Ibuprofen | Intervention Type: DRUG; Name: Acetazolamide; Assigned to Arm(s): acetazolamide
B: Arm Label: Dexamethasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethasone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Dexamethasone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Erythropoietin; Type: EXPERIMENTAL; Interventions: Drug: Erythropoietin | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Erythropoietin; Assigned to Arm(s): Erythropoietin
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: ascent protocol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ascent protocol | Intervention Type: BEHAVIORAL; Name: ascent protocol; Assigned to Arm(s): 1, 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clinical Prediction Rule for Identifying Patients With Chronic Neck Pain Who Will Benefit From General Aerobic Exercise
Brief Summary: The aim of the study is to investigate the effect of aerobic exercise on chronic neck pain. The study will be double blind randomized controlled trial . 120 patients with neck pain will be recruited for the study and divided into a research group and control group. The research group will receive neck exercise program with neck massage and aerobic exercise (leg bicycling with relaxed shoulders) and the control group will receive only neck exercise program with neck massage. Both intervention will be delivered by physiotherapist over 10 treatments and will include a home exercise program. In addition, clinical prediction rule (CPR) for identifying patients with neck pain who will respond better to an aerobic treatment program will be defined.


Options:
A: Arm Label: Exercise and connective tissue massage; Type: EXPERIMENTAL; Interventions: Behavioral: "Exercise" and "connective tissue massage" | Arm Label: Exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: "Exercise" | Intervention Type: BEHAVIORAL; Name: "Exercise" and "connective tissue massage"; Assigned to Arm(s): Exercise and connective tissue massage | Intervention Type: BEHAVIORAL; Name: "Exercise"; Assigned to Arm(s): Exercise
B: Arm Label: Group I Experimental: thoracic manipulation; Type: EXPERIMENTAL; Interventions: Other: Thoracic manipulation | Arm Label: Group II Control; Type: ACTIVE_COMPARATOR; Interventions: Other: conventional pt protocol | Intervention Type: OTHER; Name: Thoracic manipulation; Assigned to Arm(s): Group I Experimental: thoracic manipulation | Intervention Type: OTHER; Name: conventional pt protocol; Assigned to Arm(s): Group II Control
C: Arm Label: positive CPR: research group; Type: EXPERIMENTAL; Interventions: Other: physical therapy treatment with aerobic exercise | Arm Label: negative CPR: research group; Type: EXPERIMENTAL; Interventions: Other: physical therapy treatment with aerobic exercise | Arm Label: positive CPR: control group; Type: ACTIVE_COMPARATOR; Interventions: Other: physical therapy treatment | Arm Label: negative CPR: control group; Type: ACTIVE_COMPARATOR; Interventions: Other: physical therapy treatment | Intervention Type: OTHER; Name: physical therapy treatment with aerobic exercise; Assigned to Arm(s): negative CPR: research group, positive CPR: research group | Intervention Type: OTHER; Name: physical therapy treatment; Assigned to Arm(s): negative CPR: control group, positive CPR: control group
D: Arm Label: Post Isometric Relaxation; Type: EXPERIMENTAL; Interventions: Other: 1.Post Isometric Relaxation | Arm Label: Myofascial Release Therapy; Type: EXPERIMENTAL; Interventions: Other: 1.Myofascial Release therapy | Intervention Type: OTHER; Name: 1.Post Isometric Relaxation; Assigned to Arm(s): Post Isometric Relaxation | Intervention Type: OTHER; Name: 1.Myofascial Release therapy; Assigned to Arm(s): Myofascial Release Therapy

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome
Brief Summary: The objective of the study is to investigate whether prophylactic treatment with melatonin has an effect on depressive symptoms. Secondarily melatonin's effect on anxiety, sleep and circadian disturbances will be investigated.

The MEDACIS trial is a randomised, placebo-controlled, double-blinded multicenter trial investigating the effect of 25 mg exogenous melatonin (intervention group) against placebo (control group) and the study is designed as a parallel group superiority trial.


Options:
A: Arm Label: Melatonin (N-acetyl-5-methoxytryptamine); Type: ACTIVE_COMPARATOR; Interventions: Drug: Melatonin (N-acetyl-5-methoxytryptamine) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Melatonin (N-acetyl-5-methoxytryptamine); Assigned to Arm(s): Melatonin (N-acetyl-5-methoxytryptamine) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: ICU Diaries; Type: EXPERIMENTAL; Interventions: Behavioral: ICU Diary | Arm Label: Psychoeducation; Type: EXPERIMENTAL; Interventions: Behavioral: Psychoeducation | Arm Label: ICU Diary plus Psychoeducation; Type: EXPERIMENTAL; Interventions: Behavioral: ICU Diary, Behavioral: Psychoeducation | Arm Label: Treatment as Usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ICU Diary; Assigned to Arm(s): ICU Diaries, ICU Diary plus Psychoeducation | Intervention Type: BEHAVIORAL; Name: Psychoeducation; Assigned to Arm(s): ICU Diary plus Psychoeducation, Psychoeducation
C: Arm Label: Escitalopram; Type: EXPERIMENTAL; Interventions: Drug: Escitalopram | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): Escitalopram | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: BA-LVR; Type: EXPERIMENTAL; Interventions: Behavioral: BA-LVR | Arm Label: ST-LVR; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: ST-LVR | Intervention Type: BEHAVIORAL; Name: BA-LVR; Assigned to Arm(s): BA-LVR | Intervention Type: BEHAVIORAL; Name: ST-LVR; Assigned to Arm(s): ST-LVR

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Can Electronic Adherence Monitors With Feedback and Daily Reminders Improve Adherence and Health Outcomes in Children With Asthma?
Brief Summary: To determine whether electronic adherence monitoring with feedback and reminder alarms can improve adherence and health outcomes in childhood asthma.


Options:
A: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: School-based Care; Type: EXPERIMENTAL; Interventions: Behavioral: School-based Care | Intervention Type: BEHAVIORAL; Name: School-based Care; Assigned to Arm(s): School-based Care
B: Arm Label: Multifaceted intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Multifaceted intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Multifaceted intervention; Assigned to Arm(s): Multifaceted intervention
C: Arm Label: peer-led asthma self-managment program; Type: EXPERIMENTAL; Interventions: Behavioral: Peer-assisted asthma self-management program | Arm Label: Adult-led asthma self-management program; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Adult-led asthma self-management program | Intervention Type: BEHAVIORAL; Name: Peer-assisted asthma self-management program; Assigned to Arm(s): peer-led asthma self-managment program | Intervention Type: BEHAVIORAL; Name: Adult-led asthma self-management program; Assigned to Arm(s): Adult-led asthma self-management program
D: Arm Label: Feedback and alarms; Type: EXPERIMENTAL; Interventions: Device: Activated Smartinhaler or Smartturbo, Other: Feedback of adherence data | Arm Label: No feedback or alarms; Type: ACTIVE_COMPARATOR; Interventions: Device: Deactivated Smartinhaler or Smartturbo | Intervention Type: DEVICE; Name: Activated Smartinhaler or Smartturbo; Assigned to Arm(s): Feedback and alarms | Intervention Type: OTHER; Name: Feedback of adherence data; Assigned to Arm(s): Feedback and alarms | Intervention Type: DEVICE; Name: Deactivated Smartinhaler or Smartturbo; Assigned to Arm(s): No feedback or alarms

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Can Electronic Adherence Monitors With Feedback and Daily Reminders Improve Adherence and Health Outcomes in Children With Asthma?
Brief Summary: To determine whether electronic adherence monitoring with feedback and reminder alarms can improve adherence and health outcomes in childhood asthma.


Options:
A: Arm Label: Speech recognition (TEAM intervention); Type: EXPERIMENTAL; Interventions: Behavioral: Speech recognition | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Speech recognition; Assigned to Arm(s): Speech recognition (TEAM intervention)
B: Arm Label: Feedback and alarms; Type: EXPERIMENTAL; Interventions: Device: Activated Smartinhaler or Smartturbo, Other: Feedback of adherence data | Arm Label: No feedback or alarms; Type: ACTIVE_COMPARATOR; Interventions: Device: Deactivated Smartinhaler or Smartturbo | Intervention Type: DEVICE; Name: Activated Smartinhaler or Smartturbo; Assigned to Arm(s): Feedback and alarms | Intervention Type: OTHER; Name: Feedback of adherence data; Assigned to Arm(s): Feedback and alarms | Intervention Type: DEVICE; Name: Deactivated Smartinhaler or Smartturbo; Assigned to Arm(s): No feedback or alarms
C: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Text Messaging; Type: EXPERIMENTAL; Interventions: Behavioral: Text Messaging | Intervention Type: BEHAVIORAL; Name: Text Messaging; Assigned to Arm(s): Text Messaging
D: Arm Label: Active Feedback; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Feedback | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Active Feedback | Intervention Type: BEHAVIORAL; Name: Active Feedback; Assigned to Arm(s): Active Feedback, Control

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Can Electronic Adherence Monitors With Feedback and Daily Reminders Improve Adherence and Health Outcomes in Children With Asthma?
Brief Summary: To determine whether electronic adherence monitoring with feedback and reminder alarms can improve adherence and health outcomes in childhood asthma.


Options:
A: Intervention Type: BEHAVIORAL; Name: Shared-Decision Making; Assigned to Arm(s): N/A
B: Arm Label: Speech recognition (TEAM intervention); Type: EXPERIMENTAL; Interventions: Behavioral: Speech recognition | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Speech recognition; Assigned to Arm(s): Speech recognition (TEAM intervention)
C: Arm Label: Case Group; Type: N/A; Interventions: N/A | Arm Label: Control Group; Type: N/A; Interventions: Other: MyMediHealth access | Intervention Type: OTHER; Name: MyMediHealth access; Assigned to Arm(s): Control Group
D: Arm Label: Feedback and alarms; Type: EXPERIMENTAL; Interventions: Device: Activated Smartinhaler or Smartturbo, Other: Feedback of adherence data | Arm Label: No feedback or alarms; Type: ACTIVE_COMPARATOR; Interventions: Device: Deactivated Smartinhaler or Smartturbo | Intervention Type: DEVICE; Name: Activated Smartinhaler or Smartturbo; Assigned to Arm(s): Feedback and alarms | Intervention Type: OTHER; Name: Feedback of adherence data; Assigned to Arm(s): Feedback and alarms | Intervention Type: DEVICE; Name: Deactivated Smartinhaler or Smartturbo; Assigned to Arm(s): No feedback or alarms

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 52-Week Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Reslizumab 110 mg Fixed, Subcutaneous Dosing in Patients With Uncontrolled Asthma and Elevated Blood Eosinophils
Brief Summary: The primary objective of this study is to determine the effect of reslizumab (110 mg) administered subcutaneously every 4 weeks on clinical asthma exacerbations in adults and adolescents with asthma and elevated blood eosinophils who are inadequately controlled on standard-of-care asthma therapy.


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: MEMP1972A | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: MEMP1972A; Assigned to Arm(s): A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): B
B: Arm Label: Reslizumab; Type: EXPERIMENTAL; Interventions: Drug: Reslizumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Reslizumab; Assigned to Arm(s): Reslizumab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Reslizumab 3.0 mg/kg; Type: EXPERIMENTAL; Interventions: Drug: Reslizumab | Intervention Type: DRUG; Name: Reslizumab; Assigned to Arm(s): Reslizumab 3.0 mg/kg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Omalizumab; Type: EXPERIMENTAL; Interventions: Drug: Omalizumab, Drug: Fluticasone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Fluticasone | Intervention Type: DRUG; Name: Omalizumab; Assigned to Arm(s): Omalizumab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Fluticasone; Assigned to Arm(s): Omalizumab, Placebo

Answer: B